Cargando…
Deep Learning Based Drug Metabolites Prediction
Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003989/ https://www.ncbi.nlm.nih.gov/pubmed/32082146 http://dx.doi.org/10.3389/fphar.2019.01586 |
_version_ | 1783494638134362112 |
---|---|
author | Wang, Disha Liu, Wenjun Shen, Zihao Jiang, Lei Wang, Jie Li, Shiliang Li, Honglin |
author_facet | Wang, Disha Liu, Wenjun Shen, Zihao Jiang, Lei Wang, Jie Li, Shiliang Li, Honglin |
author_sort | Wang, Disha |
collection | PubMed |
description | Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually complementary tools for experiments. However, current metabolites prediction methods tend to have high false positive rates with low accuracy and are usually only used for specific enzyme systems. In order to overcome this difficulty, a method was developed in this paper by first establishing a database with broad coverage of SMARTS-coded metabolic reaction rule, and then extracting the molecular fingerprints of compounds to construct a classification model based on deep learning algorithms. The metabolic reaction rule database we built can supplement chemically reasonable negative reaction examples. Based on deep learning algorithms, the model could determine which reaction types are more likely to occur than the others. In the test set, our method can achieve the accuracy of 70% (Top-10), which is significantly higher than that of random guess and the rule-based method SyGMa. The results demonstrated that our method has a certain predictive ability and application value. |
format | Online Article Text |
id | pubmed-7003989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70039892020-02-20 Deep Learning Based Drug Metabolites Prediction Wang, Disha Liu, Wenjun Shen, Zihao Jiang, Lei Wang, Jie Li, Shiliang Li, Honglin Front Pharmacol Pharmacology Drug metabolism research plays a key role in the discovery and development of drugs. Based on the discovery of drug metabolites, new chemical entities can be identified and potential safety hazards caused by reactive or toxic metabolites can be minimized. Nowadays, computational methods are usually complementary tools for experiments. However, current metabolites prediction methods tend to have high false positive rates with low accuracy and are usually only used for specific enzyme systems. In order to overcome this difficulty, a method was developed in this paper by first establishing a database with broad coverage of SMARTS-coded metabolic reaction rule, and then extracting the molecular fingerprints of compounds to construct a classification model based on deep learning algorithms. The metabolic reaction rule database we built can supplement chemically reasonable negative reaction examples. Based on deep learning algorithms, the model could determine which reaction types are more likely to occur than the others. In the test set, our method can achieve the accuracy of 70% (Top-10), which is significantly higher than that of random guess and the rule-based method SyGMa. The results demonstrated that our method has a certain predictive ability and application value. Frontiers Media S.A. 2020-01-30 /pmc/articles/PMC7003989/ /pubmed/32082146 http://dx.doi.org/10.3389/fphar.2019.01586 Text en Copyright © 2020 Wang, Liu, Shen, Jiang, Wang, Li and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wang, Disha Liu, Wenjun Shen, Zihao Jiang, Lei Wang, Jie Li, Shiliang Li, Honglin Deep Learning Based Drug Metabolites Prediction |
title | Deep Learning Based Drug Metabolites Prediction |
title_full | Deep Learning Based Drug Metabolites Prediction |
title_fullStr | Deep Learning Based Drug Metabolites Prediction |
title_full_unstemmed | Deep Learning Based Drug Metabolites Prediction |
title_short | Deep Learning Based Drug Metabolites Prediction |
title_sort | deep learning based drug metabolites prediction |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003989/ https://www.ncbi.nlm.nih.gov/pubmed/32082146 http://dx.doi.org/10.3389/fphar.2019.01586 |
work_keys_str_mv | AT wangdisha deeplearningbaseddrugmetabolitesprediction AT liuwenjun deeplearningbaseddrugmetabolitesprediction AT shenzihao deeplearningbaseddrugmetabolitesprediction AT jianglei deeplearningbaseddrugmetabolitesprediction AT wangjie deeplearningbaseddrugmetabolitesprediction AT lishiliang deeplearningbaseddrugmetabolitesprediction AT lihonglin deeplearningbaseddrugmetabolitesprediction |